BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Sidoti Small-Cap Investor Conference, being held June 12-13, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a...
2024-06-12 4:16 PM EDT
BioHarvest Sciences Announces Record $2 Million Monthly Sales
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that VINIA®, the first commercialized product created on the Botanical Synthesis platform, set a record for monthly sales orders in May 2024 of US$1.98M, representing a 101% increase as compared to May 2023. Sales growth in BioHarvest's Products...
2024-06-06 8:30 AM EDT
BioHarvest Sciences Reports First Quarter 2024 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March 31, 2024. First Quarter & Subsequent 2024 Operational Highlights Revenue in the first quarter
2024-05-30 8:30 AM EDT
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023 financial results, and the recent acquisition of an expanded corporate campus. CEO Ilan Sobel...
2024-05-01 9:15 AM EDT
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technol
2024-04-30 8:00 AM EDT
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: an equipment purchase agreement for 12 state of the art G
2024-04-16 8:00 AM EDT
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables, to drive broader expansion of the Company's recently launched Contract Development and Manufacturing...
2024-03-21 8:30 AM EDT
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has been invited to participate in the Benzinga Virtual Healthcare Summit 2024 on March 20, 2024. Benzinga's Virtual Healthcare Summit is an immersive virtual event where the brightest minds in healthcare, influential...
2024-03-14 8:30 AM EDT
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of two senior hires in the areas of business development and science to spearhead key initiatives as part of the Company's recently launched CDMO Services Business Unit. "Our new CDMO Services division is such a...
2024-03-13 9:21 AM EDT
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on March 12-13, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event,...
2024-03-07 8:30 AM EST
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update webinar on Wednesday, March 13th to discuss the Company's Contract Development and Manufacturing Organization ("CDMO") business unit. The new CDMO business unit allows pharmaceutical,...
2024-02-29 11:15 AM EST
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering the Botanical Synthesis process technology, has announced the official launch of its new Contract Development and Manufacturing Organization (CDMO) business unit. The Company is also announcing that this new unit has recently signed two contracts to develop complex molecules - for a...
2024-02-26 8:30 AM EST
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 20, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), is issuing this news release to expand on and clarify its news release issued February 15, 2024 the "Original Release" regarding engagement of MZ Group, at the request of CIRO. Additional Information to Original Release Under the terms of the Agreement with MZ Group dated February 13, 2024, the Company will pay monthly...
2024-02-20 2:16 PM EST
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ will work closely with BioHarvest management to develop and implement a comprehensive capital markets...
2024-02-15 8:31 AM EST
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and sponsorship of the 2024 BIO CEO & Investor Conference, which will take place in New York City from February 26-27, 2024. Ilan Sobel, Chief Executive Officer of BioHarvest, is...
2024-02-12 8:30 AM EST
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows active Phyto-nutrient compositions without growing the plant, has issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholder Partners, 2023 marked a pivotal year for BioHarvest, highlighted by robust revenue growth, gross...
2024-01-08 8:00 AM EST
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second and final tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. In this tranche closed Friday December 22, 2023, the Company reported that it had issued Notes in the aggregate principal...
2023-12-27 8:00 AM EST
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 13, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has created a new "functional" coffee product line featuring VINIA® Red Grape Superfood, its flagship nutraceutical product. Tens of thousands of subscribers take VINIA® daily to improve blood flow, which enhances their physical energy and m
2023-12-13 8:00 AM EST
BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q3 Performance Update Presentation on Wednesday, December 13, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by Ilan Sobel, CEO of BioHarvest Sciences. "I am currently in Nashville, Tennessee, as part of a U.S. media and operational partner tour ahead of the imminent launch...
2023-12-01 2:22 PM EST
BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 29, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q3 2023 results. Q3 2023 revenue of its flagship VINIA® product reached USD 3.24M which is well within the projected range and represents 113% growth c
2023-11-29 8:00 AM EST